9 Antiviral aktivitet in vitro Raltegravir i koncentrationer på 31 ± 20 nM resulterede i 95% hæmning (IC95) af HIV- 1 replikation (i forhold til en ubehandlet virusinficeret kultur) i humane T- lymfoide cellekulturer inficeret med cellelinie- adapteret HIV- 1 variant H9IIIB.
Antiviral activity in vitro Raltegravir at concentrations of 31 ± 20 nM resulted in 95% inhibition (IC95) of HIV-1 replication (relative to an untreated virus-infected culture) in human T-lymphoid cell cultures infected with the cell-line adapted HIV-1 variant H9IIIB.